Erratum: Multidisciplinary treatment of rectal cancer: Medical oncology (Annals of Oncology (2007) vol. 18 (9) (ix114-ix121))

Annals of Oncology

Volumn 18, Issue 11, 2007, Pages 1908-1915

  Aschele, C ^a   Lonardi, S ^b  

^a GALLIERA HOSPITAL   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; HUMAN; LYMPH NODE METASTASIS; POSTOPERATIVE CARE; PREOPERATIVE CARE; RECTUM TUMOR;

RADIOSENSITIZING AGENT;

CHEMOTHERAPY, ADJUVANT; HUMANS; LYMPHATIC METASTASIS; POSTOPERATIVE CARE; PREOPERATIVE CARE; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS;

EID: 36148941380     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm478     Document Type: Erratum

References (68)

1. R. Sauer H. Becker W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
2. B.D. Minsky Adjuvant therapy for rectal cancer J Clin Oncol 20 2002 ASCO Annual Meeting Educational Book 472 477
3. L. Pahlman Optimal staging and treatment of localised rectal cancer Ann Oncol 13 Suppl. 4 2002 251 255
4. E. Kapiteijn C.A. Marijnen I.D. Nagtegaal Preoperative radioterapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 2001 638 646
5. S.R. Smalley J.K. Benedetti S.K. Williamson Phase III trial of fluorouracil based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144 J Clin Oncol 24 2006 3542 3547
6. T. André C. Boni L. Monnedji-Bondiaf Oxaliplatin, fluorouracil and lencovorin as adjuvant treatment of colon cancer N Engl J Med 350 2004 2343 2351
7. NIH Consensus Conference Adjuvant therapy for patients with colon and rectal cancer JAMA 264 1990 1444 1450
8. R.D. Madoff Chemoradiotherapy for rectal cancer—when, why, and how? N Engl J Med 351 2004 1790 1792
9. T. Rich L.L. Gunderson R. Lew Patterns of recurrence of rectal cancer after partially curative surgery Cancer 52 1983 1317 1329
10. Swedish Rectal Cancer Trial Improved survival with preoperative radiation in resectable rectal cancer N Engl J Med 27 1997 360 311
11. J.F. Bosset L. Collette G. Calais Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123
12. M.S. Roh N. Petrelli S. Wieand Phase III randomized trial of preoperative versus postoperative multimodality therapy in patients with carcinoma of the rectum (NSABP R-03) J Clin Oncol Vol 20 2001 212 221 2001 ASCO Annual Meeting Proceedings, (abstr 490)
13. L. Cionini B. Manfredi A. Sainato Randomized study of postoperative chemotherapy (CT) after preoperative chemoradiation (CTRT) in locally advanced rectal cancer (LARC). Preliminary results Proceedings of the 11st European Cancer Conference, Eur J Cancer 37 suppl 6 2001 S300 (abstr1107)
14. Aschele C, Pinto C, Rosati G, et al. Pre-operative FU-based chemoradiation +/– weekly oxaliplatin in locally advanced rectal cancer. Preliminary safety findings of the STAR (Studio Terapia Adiuvante Retto)-01 randomized trial. Proceedings of the 2007 Gastrointestinal Cancers Symposium of ASCO, January 19th–21st, Orlando (FL) (abs 233)
15. R.J. Myerson J.M. Michalski M.L. King Adjuvant radiation therapy for rectal carcinoma: predictors of outcome Int J Radiat Oncol Biol Phys 32 1995 41 50
16. J. Folkesson H. Birgisson L. Pahlman Swedish Rectal Cancer Trial: Long Lasting Benefits From Radiotherapy on Survival and Local Recurrence Rate J Clin Oncol 23 2005 5644 5650
17. R.G. Beets-Tan G.L. Beets R.F. Vliegen Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery Lancet 357 2001 497 504
18. G. Brown A.G. Radcliffe R.G. Newcombe Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging Br J Surg 90 2003 355 364
19. I. Daniels MRI predicts surgical resection margin status in patients with rectal cancer: results from the Mercury Study Group Clin Oncol 16 2004 S45 S46
20. J.E. Tepper M. O'Connell D. Niedwiecki Adjuvant therapy in rectal cancer. Analysis of stage, sex, and local control – Final report of Intergroup 0114 J Clin oncol 20 2002 1744 1750
21. L.L. Gunderson D.J. Sargent J.E. Tepper Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis J Clin Oncol 22 2004 1785 1796
22. R. Sauer Adjuvant and neoadjuvant radiotherapy and concurrent radiochemotherapy for rectal cancer Pathol Oncol Res 8 2002 7 17
23. D. Sebag-Montefiore R. Steele P. Quirke Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomised trial J Clin Oncol Vol 24 No. 18S 2001 212 221 2006 ASCO Annual Meeting Proceedings Part I, (June 20 Supplement), (abstr 3511)
24. GastroIntestinal Tumor Study Group Prolongation of disease free interval in surgically treated rectal carcinoma N Engl J Med 312 1985 1465 1472
25. H.O. Douglass C.G. Moertel R.J. Mayer Survival after post operative combination treatment of rectal cancer N Engl J Med 315 1986 1294 1295
26. J.E. Krook C.G. Moertel L.L. Gunderson Effective surgical adjuvant therapy for high-risk rectal carcinoma N Engl J Med 324 1991 709 715
27. K.N. Tveit I. Guldvog S. Hagen Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-Fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer Br J Surg 84 1997 1130 1135
28. Colorectal Cancer Collaborative Group Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials Lancet 358 2001 1291 1304
29. C. Camma M. Giunta F. Fiorica Preoperative radiotherapy for resectable rectal cancer: a meta-analysis JAMA 284 2000 1008 1015
30. B. Glimelius Chemoradiotherapy for rectal cancer—is there an optimal combination? Ann Oncol 12 2001 1039 1045
31. G.D. Weinstein T.A. Rich C.R. Shumate Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer. Int J. Rad Oncol Biol Phys 32 1995 197 204
32. C.G. Willet D. Haller G. Steele Controversies in the management of localized rectal cancer J Clin Oncol 17 1999 212 221 ASCO Annual Meeting Educational Book
33. J.P. Gerard T. Conroy F. Bonnetain Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203 J Clin Oncol 24 2006 4620 4629
34. Marijnen C, Peeters K, Putter H, et al. Long term results, toxicity and quality of life in the TME trial. 2000 Gastrointestinal Cancers Symposium of ASCO, J Clin Oncol 23: (abstr 166).
35. G. Fountzilas A. Zisiadis U. Dafni Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group Ann Oncol 10 1999 671 676
36. M. Mohiuddin M. Hayne W.F. Regine Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers Int J Radiat Oncol Biol Phys 48 2000 1075 1080
37. C. Rodel P. Martus T. Papadoupolos Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol 23 2005 8688 8696
38. J.F. Bosset Predictors of disease-free survival after preoperative radio(chemo)therapy and complete resection of T3–4 rectal cancer with or without adjuvant chemotherapy (EORTC 22921) Eur J Cancer Supplements 2005 ECCO 13 Abstract Book 3: 171 (abstr 609)
39. C. Crane H. Thames J. Skibber 5-FU-based adjuvant chemotherapy given after neoadjuvant chemoradiation and surgery for rectal cancer improves survival only among responders Eur J Cancer 37 suppl 6 2005 S271 Proceedings of the 11st European Cancer Conference, (abstr1002)
40. T.A. Rich R.C. Shepard S.T. Mosley Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy J Clin Oncol 22 2004 2214 2232
41. J.E. Byfield P. Calabro-Jones I. Klisak Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracilor ftorafur and X rays Int J Radiat Oncol Biol Phys 8 1982 1923 1933
42. A. Hartley K.F. Ho C. McConkey Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials Br J Radiol 78 2005 934 938
43. M.J. O'Connell J.A. Martenson H.S. Wieand Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery N Engl J Med 331 1994 502 507
44. J. Dunst T. Reese T. Sutter Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer J Clin Oncol 20 2002 3983 3991
45. S.Y. Ngan M. Michael J. Mackay A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer Br J Cancer 91 2004 1019 1024
46. R. Glynne-Jones J. Dunst D. Sebag-Montefiore The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been? Ann Oncol 17 2006 361 371
47. P.M. Hoff N. Janjan E.D. Saad Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer J Clin Oncol 18 2000 3529 3534
48. J. Feliu J. Calvilio A. Escribano Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy Ann Oncol 13 2002 730 736
49. C. Fernandez-Martos J. Aparicio C. Bosch Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years’ follow-up J Clin Oncol 22 2004 3016 3022
50. C. Rödel G.G. Granbenbauer T. Papadopoulos Phase I-II trial capecitabine, oxaliplatin, and radiation for rectal cancer J Clin Oncol 21 2003 3098 3104
51. G. Klautke U. kuchenmeister T. Foitzik Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer (LARC): results from a phase I/II study Br J Cancer 94 2006 976 981
52. C. Aschele M.L. Vitali G.A. Binda A phase I study of uracil/tegafur (UFT) and oral leucovorin (LV) + weekly oxaliplatin (OXA) and preoperative radiotherapy (RT) in locally advanced rectal cancer (LARC) J Clin Oncol. 2004 ASCO Annual Meeting Proceedings Vol 22 2004 (abstr 3637)
53. J.-P. Gerard O. Chapet Ch. Nemot Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: The Lyon RO-04 phase II trial J Clin Oncol 21 2003 1119 1124
54. C. Aschele M.L. Friso S. Pucciarelli A phase I-II study of weekly oxaliplatin, 5-Fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer Ann Oncol 16 2005 1140 1146
55. M. Mohiuddin K. Winter E. Mitchell Radiation Therapy Oncology Group Trial 0012. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012 J Clin Oncol 24 2006 650 655
56. K. Williams B. Telfer I. Stratford ZD1839, a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancers xenograft model Br J Cancer 86 2002 1157 1161
57. J.A. Bonner J. Giralt P. Harari Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578
58. F. Ciardiello R. Caputo R. Bianco Anti-tumor effect in potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839, an epidermal growth factor receptor-selective tyrosine kinase inhibitor Clin Cancer Res 6 2000 2053 2063
59. B.G. Czito C.G. Willett J.C. Bendell Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results J Clin Oncol 24 2006 656 662
60. J.P. Machiels C. Sempoux P. Scalliet Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer Ann Oncol 18 4 2007 738 744
61. R.D. Hofheinz K. Horisberger C. Woernle Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer Int J Radiat Oncol Biol Phys 66 2006 1384 1390
62. H. Hurwitz L. Fehrenbacher W. Novotny Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342
63. C.G. Willett S.V. Kozin D.G. Duda Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice Semin Oncol 5 Suppl. 10 2006 33 S35–S40
64. I. Chau M. Allen D. Cunningham Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer Br J Cancer 88 2003 1017 1024
65. I. Chau G. Brown D. Cunningham Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer J Clinl Oncol 24 2006 668 674
66. R. Glynne-Jones J. Grainger M. Harrison Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? Br J Cancer 94 2006 363 371
67. McLeod HL, Tan B, Malyapa R, et al. Genotype-guided neoadjuvant therapy for rectal cancer. Proceedings of 2005 ASCO Meeting. J Clin Oncol 23: abstr 3024.
68. G.L. Cascini A. Avallone P. Delrio 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer J Nucl Med 47 2006 1241 1248